TRVI
Trevi Therapeutics Inc
Clinical-stage biopharmaceutical company
CUSIP: 89532M101HealthcareUS1 holder
Total Value
$40.05M
Total Shares
3.20M
Net Share Change
-1.93M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$40.05M3.20M shares
TRIM-1.93M(-37.6%)